Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:EXAI

Exscientia (EXAI) Stock Price, News & Analysis

Exscientia logo

About Exscientia Stock (NASDAQ:EXAI)

Key Stats

Today's Range
$4.84
$4.84
50-Day Range
$4.69
$5.96
52-Week Range
$3.80
$6.49
Volume
N/A
Average Volume
713,050 shs
Market Capitalization
$632.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EXAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exscientia and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EXAI Stock News Headlines

Exscientia and Recursion Merge to Revolutionize Drug Discovery
Recursion, Exscientia officially combine to advance drug discovery
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.tc pixel
Barclays Sticks to Its Hold Rating for Exscientia Plc (EXAI)
Recursion and Exscientia Merger Approved by Shareholders
Recursion, Exscientia shareholders approve proposed combination
See More Headlines

EXAI Stock Analysis - Frequently Asked Questions

Exscientia plc (NASDAQ:EXAI) released its quarterly earnings results on Thursday, August, 15th. The company reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.31) by $0.05. The firm had revenue of $5.60 million for the quarter. Exscientia had a negative net margin of 882.09% and a negative trailing twelve-month return on equity of 49.10%.

Exscientia (EXAI) raised $291 million in an initial public offering on Friday, October 1st 2021. The company issued 13,850,000 shares at a price of $20.00-$22.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Exscientia investors own include AU Optronics (AUOTY), Waste Connections (WCN), American Water Works (AWK), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
8/15/2024
Today
10/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:EXAI
CIK
1865408
Fax
N/A
Employees
280
Year Founded
2012

Profitability

EPS (Trailing Twelve Months)
($1.51)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$181.56 million
Net Margins
-882.09%
Pretax Margin
-904.93%
Return on Equity
-49.10%
Return on Assets
-33.13%

Debt

Debt-to-Equity Ratio
0.06
Current Ratio
4.54
Quick Ratio
4.54

Sales & Book Value

Annual Sales
$25.60 million
Price / Sales
24.72
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.54 per share
Price / Book
1.91

Miscellaneous

Outstanding Shares
130,770,000
Free Float
109,324,000
Market Cap
$632.93 million
Optionable
Optionable
Beta
0.83

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:EXAI) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners